ATE282403T1 - Verwendung eines planzenextraktes aus der familie der rosaceae - Google Patents

Verwendung eines planzenextraktes aus der familie der rosaceae

Info

Publication number
ATE282403T1
ATE282403T1 AT98402056T AT98402056T ATE282403T1 AT E282403 T1 ATE282403 T1 AT E282403T1 AT 98402056 T AT98402056 T AT 98402056T AT 98402056 T AT98402056 T AT 98402056T AT E282403 T1 ATE282403 T1 AT E282403T1
Authority
AT
Austria
Prior art keywords
antagonist
alpha
activity
plant extract
rosaceae family
Prior art date
Application number
AT98402056T
Other languages
English (en)
Inventor
Lionel Breton
Nathalie Pineau
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9511325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE282403(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE282403T1 publication Critical patent/ATE282403T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98402056T 1997-09-22 1998-08-13 Verwendung eines planzenextraktes aus der familie der rosaceae ATE282403T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9711761A FR2768621B1 (fr) 1997-09-22 1997-09-22 Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees

Publications (1)

Publication Number Publication Date
ATE282403T1 true ATE282403T1 (de) 2004-12-15

Family

ID=9511325

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98402056T ATE282403T1 (de) 1997-09-22 1998-08-13 Verwendung eines planzenextraktes aus der familie der rosaceae

Country Status (8)

Country Link
US (1) US6146636A (de)
EP (2) EP0906752B1 (de)
JP (1) JP3186709B2 (de)
AT (1) ATE282403T1 (de)
CA (1) CA2245125C (de)
DE (1) DE69827579T2 (de)
ES (1) ES2234083T3 (de)
FR (1) FR2768621B1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2132855T3 (es) * 1995-09-07 1999-08-16 Oreal Extracto de iridaceas y composiciones que lo contienen.
EP1104672A1 (de) * 1999-12-02 2001-06-06 Laboratoires Serobiologiques(Societe Anonyme) Kosmetische und/oder pharmazeutische Zubereitungen
KR100628480B1 (ko) * 1999-12-02 2006-09-27 주식회사 엘지생활건강 선학초 추출물을 유효 성분으로 함유하는 항자극 화장료조성물
KR100327762B1 (ko) * 2000-01-25 2002-03-15 이영성, 권두한 짚신나물로부터 분리한 ｂ형 간염바이러스 표면항원생성억제물질과 그 추출방법 및 용도
US6403123B1 (en) * 2000-09-19 2002-06-11 Eugene J. Van Scott Method for topical treatment of anthralin-responsive dermatological disorders
FR2814364B1 (fr) * 2000-09-25 2005-08-26 Elise Annie Imbert Preparation a usage topique pour recolorer regenerer, les cheveux blancs, et amiliorer l'etat de la peau
US6583184B1 (en) * 2000-11-27 2003-06-24 Avon Products, Inc. Compositions having comfrey and methods for reducing retinoid-induced skin irritation
KR100406124B1 (ko) * 2001-03-30 2003-11-15 주식회사 태평양 자외선에 의해 증가하는 프로스타글란딘을 억제하는성분과 멜라닌 합성을 억제하는 성분을 동시에 함유하는미백 화장료 조성물
US7195788B2 (en) 2001-03-30 2007-03-27 Premier Botanicals, Ltd. Pesticidal compositions from prunus
US6709651B2 (en) 2001-07-03 2004-03-23 B.M.R.A. Corporation B.V. Treatment of substance P-related disorders
KR100444599B1 (ko) * 2001-08-17 2004-08-16 주식회사 태평양 피부자극 및 염증완화 효과를 갖는 라스베리 잎 또는 열매추출물을 함유한 피부 외용제 조성물
EP1427806A4 (de) * 2001-08-31 2006-04-26 Chiron Corp Antigene hiv-typ-b-polypeptide codierende polynukleotide, polypeptide und verwendungen davon
KR20010099494A (ko) * 2001-10-09 2001-11-09 이영성, 권두한 큰등골짚신나물로부터 분리한 ｂ형 간염바이러스 표면항원억제물질과 그 추출방법 및 용도
EP1325682A1 (de) * 2001-12-11 2003-07-09 Societe Des Produits Nestle S.A. Lebensmittel- oder Tierfutterzusammensetzung enthaltend Pflanzenextracte für den Erhalt der Knochen und die Vorbeugung oder Heilung von Knochenkrankheiten
US20030225326A1 (en) * 2002-04-03 2003-12-04 Bernard Querleux Methods and combinations relating to information obtained using brain imaging techniques
FR2838040B1 (fr) * 2002-04-03 2004-07-02 Oreal Procede pour verifier l'efficacite d'un produit destine a exercer une action sur la sensibilite de la peau
FR2846558B1 (fr) * 2002-11-05 2006-07-14 Servier Lab Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales
WO2004105689A2 (en) * 2003-05-22 2004-12-09 Host Pharmaceuticals, Llc Topical composition for the treatment of skin disorders and methods of using the same
WO2005025586A1 (en) * 2003-09-12 2005-03-24 Access Business Group International Llc Cytokine modulators and related method of use
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
CA2567637A1 (en) * 2004-05-31 2005-12-08 Munisekhar Medasani Using organic and/or inorganic potassium and its salts to treat autoimmune and other health disorders and methods of administering the same
US8221766B2 (en) * 2004-12-22 2012-07-17 Avon Products, Inc. Use of plant extracts to prevent and/or reduce the signs of subjective discomfort and/or irritation in the topical application of cosmetic products
US7300649B2 (en) 2005-02-11 2007-11-27 Genepharm, Inc. Cosmetic and cosmeceutical compositions for restoration of skin barrier function
JP2006316026A (ja) * 2005-05-16 2006-11-24 American Biologics Japan Kk バラ科植物抽出物等およびそれらを利用した免疫細胞活性化剤
US20100055218A1 (en) * 2006-07-14 2010-03-04 Daniel Raederstorff Novel compositions
FR2926021B1 (fr) * 2008-01-03 2012-12-14 Oreal Utilisation de derives c-glycoside a titre d'actif vasculaire
WO2009133586A1 (ja) * 2008-04-28 2009-11-05 有限会社アンティアンティ アルツハイマー病の治療医薬
KR101035758B1 (ko) * 2009-06-03 2011-05-20 충북대학교 산학협력단 복분자 추출물을 포함하는 심장비대 치료 및 예방용 약제학적 조성물, 및 심장비대 완화용 건강기능식품
KR101223662B1 (ko) * 2009-12-28 2013-01-17 대한민국(농촌진흥청장) 짚신나물 추출물을 포함하는 진통제 조성물
US10463603B2 (en) * 2012-01-05 2019-11-05 L'oreal Cosmetic use of dedifferentiated plant cells
KR101384351B1 (ko) * 2012-02-14 2014-04-14 충북대학교 산학협력단 장미꽃 추출물을 유효성분으로 포함하는 허혈성 뇌질환 치료용 조성물
EP2752183B1 (de) 2013-01-07 2015-04-22 Golüke, Timm Kosmetikum mit biologischem Naturstoffkomplex
JP6317993B2 (ja) * 2014-05-07 2018-04-25 ポーラ化成工業株式会社 肌改善剤のスクリーニング方法
JP2020176065A (ja) * 2019-04-15 2020-10-29 共栄化学工業株式会社 皮膚外用剤
JP6777794B1 (ja) * 2019-07-04 2020-10-28 株式会社ファンケル コラーゲン産生促進用組成物
FR3099370B1 (fr) * 2019-08-01 2022-03-11 Nissactive Extrait de tiges de rosier, composition comprenant l'extrait et utilisation cosmétique dudit extrait et de la composition
FR3104416A1 (fr) * 2019-12-12 2021-06-18 L V M H Recherche Extraits de bourgeons de roses

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035747A1 (en) * 1969-02-04 1970-12-24 Investigation Scien Phar Coronary-and varo-dilatory prepns from - poterium spinosum
FR2366836A1 (fr) * 1976-10-08 1978-05-05 Cariel Leon Nouveau produit pour le traitement curatif et preventif du tissu conjonctif
DE2753466A1 (de) * 1977-11-30 1979-05-31 Sertog Verwendung von extrakten von pflanzen der art prunus
JPS59166075A (ja) * 1983-03-10 1984-09-19 Youmeishiyu Seizo Kk 低アルコ−ル性醸造酒
JP3027409B2 (ja) * 1990-11-29 2000-04-04 有限会社野々川商事 化粧料
FR2690344B1 (fr) * 1992-04-27 1994-07-01 Inkeysa Sa Compositions therapeutiques a dosage topique dans le traitement effectif de la psoriasis.
JP3480952B2 (ja) * 1992-08-17 2003-12-22 株式会社コーセー 皮膚外用剤
TW391878B (en) * 1992-10-07 2000-06-01 Eisai Co Ltd Pharmaceutical composition or feedstuff comprising at least one of rosa roxburghii, artemisiae argyi folium and brassica oleracea var. capitata l.
JPH06206814A (ja) * 1992-11-20 1994-07-26 Earth Chem Corp Ltd 入浴剤
CN1037143C (zh) * 1993-11-19 1998-01-28 黄宏全 一种保健茶及制备方法
JP3320879B2 (ja) * 1993-12-27 2002-09-03 アサヒビール株式会社 抗ガストリン剤
FR2722691A1 (fr) * 1994-07-22 1996-01-26 Oreal Composition cosmetique et/ou dermatologique conten lutter contre l'acne ou le vieillissement ant de l'eau thermale ou minerale et un actif pour
JP3803398B2 (ja) * 1994-08-01 2006-08-02 ポーラ化成工業株式会社 人体過剰対応抑制剤
FR2729859B1 (fr) * 1995-01-31 1997-04-04 Rochas Parfums Compositions comportant une huile essentielle et/ou une absolue pour le traitement, en application topique, de l'inflammation
EP0727217A3 (de) * 1995-02-10 1997-01-15 Suntory Ltd Pharmazeutische und kosmetische Zusammensetzungen enthaltend God-Typ-Ellagitannin als Wirkstoff
FR2732221B1 (fr) * 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
FR2736263B1 (fr) * 1995-07-07 1997-09-26 C3D Sarl Composition dermocosmetique depigmentante et son utilisation
ES2132855T3 (es) * 1995-09-07 1999-08-16 Oreal Extracto de iridaceas y composiciones que lo contienen.
FR2738741B1 (fr) * 1995-09-19 1997-12-05 Oreal Composition pour la teinture des fibres keratiniques, contenant un antagoniste de substance p
FR2744915B1 (fr) * 1996-02-16 1998-03-27 Oreal Composition cosmetique a base de cellules indifferenciees de ginkgo biloba
DE19611078C2 (de) * 1996-03-21 1997-10-02 Osama L M Dr Med Dr Rer N Omer Therapie von chronischen entzündlichen Darmerkrankungen mit einer Phytokombination
JPH1036279A (ja) * 1996-07-18 1998-02-10 Ichimaru Pharcos Co Ltd 植物抽出物含有線維芽細胞増殖促進剤

Also Published As

Publication number Publication date
US6146636A (en) 2000-11-14
EP1491183A2 (de) 2004-12-29
EP1491183A3 (de) 2005-02-02
EP0906752A1 (de) 1999-04-07
DE69827579D1 (de) 2004-12-23
FR2768621B1 (fr) 2000-04-07
ES2234083T3 (es) 2005-06-16
EP0906752B1 (de) 2004-11-17
CA2245125C (fr) 2008-11-18
CA2245125A1 (fr) 1999-03-22
FR2768621A1 (fr) 1999-03-26
JP3186709B2 (ja) 2001-07-11
DE69827579T2 (de) 2005-12-01
JPH11180879A (ja) 1999-07-06

Similar Documents

Publication Publication Date Title
DE69827579D1 (de) Verwendung eines Planzenextraktes aus der Familie der Rosaceae
GT200000002AA (es) Ureas difenilicias x-carboxiaril sustituidas como inhibidores de raf quinasa
ATE529109T1 (de) Hemmung der p38 kinase aktivität durch substituierte heterocyclische harnstoffe
WO2002042295A3 (en) Peptides as met-ap2 inhibitors
PL351125A1 (en) Derivatives of 4,5-diaryl-3(2)-furanone as inhibitors of cykoxygenease-2
DE69706407D1 (de) META-SUBSTITUIERTE PHENYLENDERIVATE UND IHRE VERWENDUNG ALS ALPHAvBETA3 INTERGRIN-ANTAGONISTEN ODER INHIBITOREN
LU91680I2 (fr) "rilonacept et ses dérivés pharmaceutiquement acceptables (ARCALYSR)"
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
RS50924B (sr) Oralni dozni oblici propiverina ili njegovih farmaceutski prihvatljivih soli sa produženim oslobađanjem aktivne materije
EP1707563A3 (de) Chinazolinone Benutzende Verfahren und Zusammenstellungen
HUP9903918A2 (hu) Fibrózis gátlására alkalmas szomatosztatin agonistát tartalmazó gyógyszerkészítmények
NO20040211L (no) Kombinasjon av en aldosteronreseptor for antagonist og en HMB COA-reduktaseinhibitor
DK0951295T3 (da) Sammensætninger til anvendelse ved inhibering af alfa-v-beta3-medieret angiogenese
DE60037726D1 (de) Carbonsäurederivate die die bindung von integrinen an ihre rezeptoren hemmen
ATE360419T1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
WO2003091259A8 (en) Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
ATE452884T1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
WO2001056573A8 (en) Use of cox-2 inhibitors as gastroprokinetics
ATE317693T1 (de) Substituierte stilbene mit gefässschädigender aktivität
ES2138595T3 (es) Inhibidores de citoquinas.
EP1435941B8 (de) Wortmanninanaloge und verfahren zu deren verwendung
CA2749289A1 (en) Use of active extracts to improve the appearance of skin, lips, hair and/or nails
WO2002000183A3 (en) Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin
NZ516620A (en) 1,4-substituted 4,4-diaryl cyclohexanes
BR0110902A (pt) Inibidores de mmp-9/mmp-2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties